Skip to main content
Top
Published in: Rheumatology International 7/2009

01-05-2009 | Original Article

Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients

Authors: Yong Dai, Weiguo Sui, Huijuan Lan, Qiang Yan, He Huang, YuanShuai Huang

Published in: Rheumatology International | Issue 7/2009

Login to get access

Abstract

MicroRNAs (miRNAs) are noncoding RNA molecules of 21–24 nt that regulate the expression of target genes in a post-transcriptional manner. Evidence indicates that miRNAs play essential roles in embryogenesis, cell differentiation, and pathogenesis of human diseases. This study describes a comparison between the miRNA profile of kidney biopsies from lupus nephritis (LN) patients and the controls, to develop further understanding of the pathogenesis of LN. Kidney biopsies were taken from five LN patients detected LN Class II and three normal controls. The miRNA microarray chip analysis identified 66 miRNAs differentially expressed in LN. The chip results were confirmed by QRT-PCR. This work indicates that miRNAs are potential diagnosis biomarkers and probable factors involved in the pathogenesis of LN.
Literature
1.
go back to reference Wallace DJ, Hahn BH (1997) Dubois’ Lupus Erythematosus. Williams & Wilkins, Baltimore Wallace DJ, Hahn BH (1997) Dubois’ Lupus Erythematosus. Williams & Wilkins, Baltimore
2.
go back to reference Nossent JC, Bronsveld W, Swaak AJ (1989) Systemic lupus erythematosus. III. Observations on clinical renal involvement and follow up of renal function: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 48:810–816. doi:10.1136/ard.48.10.810 PubMedCrossRef Nossent JC, Bronsveld W, Swaak AJ (1989) Systemic lupus erythematosus. III. Observations on clinical renal involvement and follow up of renal function: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 48:810–816. doi:10.​1136/​ard.​48.​10.​810 PubMedCrossRef
19.
21.
go back to reference Rovin BH, Birmingham DJ, Nagaraja HN, Yu CY, Hebert LA (2007) Biomarker discovery in human SLE nephritis. Bull NYU Hosp Jt Dis 65(3):187–193PubMed Rovin BH, Birmingham DJ, Nagaraja HN, Yu CY, Hebert LA (2007) Biomarker discovery in human SLE nephritis. Bull NYU Hosp Jt Dis 65(3):187–193PubMed
22.
go back to reference Fukao T, Fukuda Y, Kiga K, Sharif J, Hino K, Enomoto Y, Kawamura A, Nakamura K, Takeuchi T, Tanabe M (2007) An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 129(3):617–631. doi:10.1016/j.cell.2007.02.048 PubMedCrossRef Fukao T, Fukuda Y, Kiga K, Sharif J, Hino K, Enomoto Y, Kawamura A, Nakamura K, Takeuchi T, Tanabe M (2007) An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 129(3):617–631. doi:10.​1016/​j.​cell.​2007.​02.​048 PubMedCrossRef
23.
go back to reference Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, Gomella LG, Croce CM, Baffa R (2007) Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25(5):387–392. doi:10.1016/j.urolonc.2007.01.019 PubMed Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, Gomella LG, Croce CM, Baffa R (2007) Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25(5):387–392. doi:10.​1016/​j.​urolonc.​2007.​01.​019 PubMed
Metadata
Title
Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients
Authors
Yong Dai
Weiguo Sui
Huijuan Lan
Qiang Yan
He Huang
YuanShuai Huang
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 7/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0758-6

Other articles of this Issue 7/2009

Rheumatology International 7/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.